As the second European QA conference in Nice is fast approaching, we would like to extend our welcome to you and invite you to come and visit ADAMAS Consulting on Stand 5 of the Nice Acropolis Convention and Exhibition centre. Members of the ADAMAS team are very much looking forward to the opportunity to meet you and discuss the extensive GxP services that ADAMAS offers.

The conference has a host of exciting and interesting topics, including Electronic media, Data integrity and CAPA management on Day 1, with Day 2 covering FDA inspections, risk based QA in GLP and what we are sure will be an interesting PV QA round table with regulators. This is a unique opportunity to interact with different European regulatory authorities and QA societies, with the exchange of information and sharing of best practice. In keeping with this spirit of European harmonization, the Key Note speaker on Day 1 will be reviewing the forthcoming European Clinical Trial regulation and asking whether it goes far enough to standardise pharmaceutical and clinical development activities.

ADAMAS is also displaying two highly innovative posters for you to visit:

  • Conducting Remote Audits
  • Investigator Oversight-Five Chronic Observations

Jerry Young (Business Development Manager EMEA), Angela McCullagh (Operations Manager) and Mandy Hall-Dryden (Principle Consultant) will be attending the conference and would be delighted to meet with you to discuss any aspects of our GxP auditing and training services.

We look forward to meet you there!

The ADAMAS Corporate Brochure 2016


Brochure – Please download the ADAMAS brochure describing our QA services and contact details.

Regulatory Environment


The development of medicines is the most regulated industry in the world, and compliance at each stage of the research and development process, as well as after licensing, is critical to ensuring high quality and safe medicines reach patients in a timely manner.



ADAMAS’s consultants have expertise across the G’X’Ps in pre-clinical, clinical and post-licensing areas. They have worked across many different therapeutic areas and product types including oncology, vaccines, biologics, medical devices and gene therapy. As a company we have developed close partnerships with our clients to support them in their development programmes and post-licensing activities, and to guide them successfully through their worldwide regulatory inspections.


How to be a Clinical Auditor


‘So you want to be a Clinical Auditor?’, an article written by CEO Dr. Patricia Fitzgerald.

Benchmarking Data


Please download our benchmarking data sheet, to see how these data compare with your own performance. To discuss a more detailed report, or analysis of a data subset, please get in touch.

Is your QMS compliant?


Is your QMS compliant to the upcoming ICH E6 Addendum? Download our 5-point checklist

ICH (E6) R2 Addendum - Step 4


Please enter your details to complete the download.



Want to become one of the first businesses to access our exclusive data?
Get going and start reducing risk today. Pre register now.